Colic Clinical Trial
Official title:
Evaluate the Analgesic Effect of Intraperitoneal Infiltration of Ropivacaine in Children Undergoing Laparoscopic Surgery
The aim of this study was to evaluate the analgesic effect of intraperitoneal infiltration of ropivacaine in children undergoing laparoscopic surgery.
1. Quality assurance plan that addresses data validation and registry procedures,
including any plans for site monitoring and auditing.
2. Data checks to compare data entered into the registry against predefined rules for
range or consistency with other data fields in the registry.
3. Source data verification to assess the accuracy, completeness, or representativeness of
registry data by comparing the data to external data sources .
4. Data dictionary that contains detailed descriptions of each variable used by the
registry, including the source of the variable, coding information .
5. Standard Operating Procedures to address registry operations and analysis activities,
such as patient recruitment, data collection, data management, data analysis, reporting
for adverse events, and change management.
6. Sample size assessment to specify the number of participants or participant years
necessary to demonstrate an effect.
7. Plan for missing data to address situations where variables are reported as missing,
unavailable, "non-reported," uninterpretable, or considered missing because of data
inconsistency or out-of-range results
8. Statistical analysis plan describing the analytical principles and statistical
techniques to be employed in order to address the primary and secondary objectives, as
specified in the study protocol or plan
;
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Investigator, Outcomes Assessor), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01849991 -
Safety and Effect of L. Reuteri on Biomarkers of Inflammation in Healthy Infants With Colic
|
Phase 1 | |
| Completed |
NCT01279265 -
Effect of Lactobacillus Rhamnosus GG (LGG) on Infant Colic
|
N/A | |
| Completed |
NCT00177086 -
Alfuzosin Hydrochloride to Promote Passage of Distal Ureteral Calculi
|
Phase 3 | |
| Not yet recruiting |
NCT02577133 -
Prevention of Colic With the Probiotic Lactobacillus Reuteri
|
Phase 2/Phase 3 | |
| Recruiting |
NCT01715220 -
Treatment of Suspected Cholelithiasis With Nitroglycerin
|
Phase 2 | |
| Completed |
NCT00922727 -
Safety of Lactobacillus Reuteri (L. Reuteri) in Healthy Adults
|
Phase 1 | |
| Completed |
NCT02865564 -
Effect of Lactobacillus Reuteri DSM17938 in Neonates Treated With Antibiotics
|
N/A | |
| Completed |
NCT01541046 -
Lactobacillus Reuteri DSM 17938 Versus Placebo in the Treatment of Infantile Colic
|
Phase 2 | |
| Completed |
NCT00929292 -
Safety and Tolerance Study of Alpha-Lactalbumin Enriched and Probiotic-Supplemented Infant Formula in Infants With Colic
|
Phase 3 | |
| Recruiting |
NCT05554991 -
Human Milk Oligosaccharide (HMO) Supplementation in Colic Management
|
N/A | |
| Recruiting |
NCT01067027 -
Control of Colic in Infants by Dietary Supplementation With the Probiotic Lactobacillus Reuteri
|
Phase 4 | |
| Recruiting |
NCT04983069 -
Neonatal Outcome of Children With Antenatal Colic Hyperechogenicity
|
||
| Recruiting |
NCT05685030 -
Probiotics Strains for Infant Colic
|
Phase 2 | |
| Withdrawn |
NCT05198700 -
The Effect of Probiotics on Symptoms of Infantile Colic
|
Phase 2 | |
| Terminated |
NCT02586558 -
Effect of a Prebiotic on Colic and Crying and Fussing Behaviour in Infants
|
N/A | |
| Completed |
NCT01532518 -
Preliminary Efficacy, Safety and Pharmacokinetics Study of Nepadutant in Infant With Feeding Intolerance
|
Phase 2 | |
| Completed |
NCT00796523 -
An Intervention to Decrease Infant Crying
|
N/A | |
| Completed |
NCT05052476 -
First Line Dose-efficacy Study of Bactecal® D Liquid for Infant Colic
|
N/A | |
| Completed |
NCT02242292 -
Study to Evaluate Efficacy and Safety of Oral Doses of Hyoscine Butylbromide for the Treatment of Occasional Abdominal Pain, Cramping, and Discomfort
|
Phase 2 | |
| Terminated |
NCT00139646 -
Parecoxib in Renal Colic
|
Phase 3 |